Centers for Disease Control and Prevention (CDC) (2013) Impact of an Innovative Approach to Prevent Mother-to-Child Transmission of HIV—Malawi, July 2011-September 2012. Morbidity and Mortality Weekly Report, 62, 148-151. www.cdc.gov/mmwr/preview/mmwrhtml/mm6208a3.htm

has been cited by the following article:

• TITLE: One-Year Outcomes of Women Started on Antiretroviral Therapy during Pregnancy before and after the Implementation of Option B+ in Malawi: A Retrospective Chart Review from Three Facilities

  AUTHORS: Alfred A. Kamuyango, Lisa R. Hirschhorn, Wenjia Wang, Perry Jansen, Risa M. Hoffman

  KEYWORDS: Antiretroviral Therapy, Pregnancy, Option B+, Prevention of Mother-to-Child Transmission

  JOURNAL NAME: World Journal of AIDS, Vol.4 No.3, August 28, 2014

  ABSTRACT: Objective: To compare one-year outcomes of women started on antiretroviral therapy (ART) duringpregnancy in the pre-Option B+ era to those in the Option B+ era. Methods: A retrospective chart review was performed at three sites in Malawi. Women were included in the “pre-Option B+” cohort if they started ART during pregnancy for a CD4 count 3or WHO 3/4 condition and in the “Option B+” cohort if they started ART during pregnancy regardless of CD4 count or clinical stage. One-year outcomes were compared using Fisher’s exact and ANOVA F-tests. Results: A higher proportion of women in the pre-Option B+ cohort started ART at WHO stage 3/4 (11.9% versus 1.1%, P